Relugolix Nitroso Impurity 1

Relugolix Nitroso Impurity 1

It is one of impurity present in Relugolix, Relugolix is a gonadotropin-releasing hormone receptor antagonist, Cytochrome P450 3A Inducer, and Cytochrome P450 2B6 Inducer and Breast Cancer Resistance Protein Inhibitor, and P-Glycoprotein Inhibitor. the physiologic effect of relugolix is using Decreased GnRH Secretion. which is used for androgen deprivation therapy in the treatment of advanced prostate cancer.

Additional information on Relugolix Nitroso Impurity 1

Catalogue No.

VE009886
CAS No.

N/A
Molecular Formula

C28H24F2N8O6S
Molecular Weight

638.6 g/mol
Parent drug

Relugolix
IUPAC Name

1-(4-(1-(2, 6-difluorobenzyl)-3-(6-methoxypyridazin-3-yl)-5-((methyl(nitroso)amino)methyl)-2, 4-dioxo-1, 2, 3, 4-tetrahydrothieno[2, 3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea
Synonyms

N/A
References

Saad, F., & Shore, N. D. (2021). Relugolix: a novel androgen deprivation therapy for management of patients with advanced prostate cancer. Therapeutic Advances in Medical Oncology, 13, 175883592199858. https://doi.org/10.1177/1758835921998586
Status

In-stock

Other products related to relugolix

Request a quote

Relugolix Nitroso Impurity 1

Relugolix Nitroso Impurity 1
Catalogue No.

VE009886
CAS No.

N/A
Molecular Formula

C28H24F2N8O6S
Molecular Weight

638.6 g/mol
Parent drug

Relugolix
IUPAC Name

1-(4-(1-(2, 6-difluorobenzyl)-3-(6-methoxypyridazin-3-yl)-5-((methyl(nitroso)amino)methyl)-2, 4-dioxo-1, 2, 3, 4-tetrahydrothieno[2, 3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea
Synonyms

N/A
References

Saad, F., & Shore, N. D. (2021). Relugolix: a novel androgen deprivation therapy for management of patients with advanced prostate cancer. Therapeutic Advances in Medical Oncology, 13, 175883592199858. https://doi.org/10.1177/1758835921998586
Status

In-stock
ListName

Relugolix Nitroso Impurity 1
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url